STOCK TITAN
  1. Home
  2. News
  3. PRME

Prime Medicine Inc - PRME STOCK NEWS

IMPACT
SENTIMENT
PRME : Nasdaq
Prime Medicine to Highlight Positive Preclinical Developments Across Prime Editing Pipeline and Platform at Upcoming Industry Conferences
clinical trial
IMPACT
SENTIMENT
PRME : Nasdaq
Prime Medicine to Present at Upcoming Investor Conferences
conferences
IMPACT
SENTIMENT
PRME : Nasdaq
Prime Medicine to Present at Upcoming Investor Conferences
conferences
IMPACT
SENTIMENT
PRME : Nasdaq
Prime Medicine Reports Second Quarter 2023 Financial Results and Provides Business Updates
earnings
IMPACT
SENTIMENT
PRME : Nasdaq
Prime Medicine and Cimeio Therapeutics Announce Research Collaboration to Develop Prime Edited Shielded-Cell & Immunotherapy Pairs™ for Genetic Diseases, Acute Myeloid Leukemia and Myelodysplastic Syndrome
IMPACT
SENTIMENT
PRME : Nasdaq
Prime Medicine to Present at Investor Conferences in June
conferences
IMPACT
SENTIMENT
PRME : Nasdaq
Prime Medicine to Present at Virtual Investor Conferences in May
conferences
IMPACT
SENTIMENT
PRME : Nasdaq
Prime Medicine to Present New Preclinical Data Highlighting Broad Potential of Prime Editing Technology at ASGCT 26th Annual Meeting
conferences clinical trial
IMPACT
SENTIMENT
PRME : Nasdaq
Prime Medicine Reports First Quarter 2023 Financial Results and Provides Business Updates
earnings
IMPACT
SENTIMENT
PRME : Nasdaq
Prime Medicine to Present at Guggenheim Healthcare Talks – Genomic Medicines and Rare Disease Days
conferences
Stock PRME logo
Prime Medicine Inc
Nasdaq:PRME

PRME Stock Data

Research and Development in Biotechnology
Professional, Scientific, and Technical Services